- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
As Nation Braces For Obamacare, Mass. Tackles Health Costs
If for some reason you're not already drowning in the rough waters of U.S. health policy - what with the Affordable Care Act's health exchanges launching today and Congress and President Obama still duking it out over the four-year-old law upheld by the U.S. Supreme Court - well, you're in luck.
If for some reason you’re not already drowning in the rough waters of U.S. health policy — what with the Affordable Care Act’s health exchanges launching today and Congress and President Obama still duking it out over the four-year-old law upheld by the U.S. Supreme Court — well, you’re in luck. Because in the midst of all this Obamacare angst and government shutdown, our fair state this week kicks off the Oscars of health wonkdom, aka, the Massachusetts Health Policy Commission’s Annual Health Care Cost Trends Hearing.
It’s a time for state health care officials and bureaucrats to conduct a little reality check with insurers, hospitals, businesses and consumers to ensure that everyone’s making a good-faith effort to hold down medical costs.
Stuart Altman, economist and professor of National Health Policy at Brandeis University and chair of the board of the Massachusetts Health Policy Commission, says the role of the commission is to keep all of the players involved in the health system accountable and sharply focused on driving down costs while improving quality. “We’re like a big searchlight on the system to say ‘Hey this is good’ or Hey, this is not good,” and then follow up, Altman said on WBUR’s Radio Boston Monday.
Read the full story here: http://bit.ly/1c4vgWA
Source: WBUR
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
